|
|
|
| |
 |
Claude Allary - Managing Partner - claude [a] bionest.com |
Claude Allary has three decades of pharmaceuticals industry and management consulting experience, in Europe and North America. He held several corporate and operational finance and marketing positions with Parke-Davis, Rhône-Poulenc Santé and Glaxo.
In his 15-year consulting experience, including Arthur D. Little and ISO Healthcare group, he was involved in over 200 projects in healthcare, including strategy and innovation. His main interest is strategy development. |
|
| |
 |
Lionel Delaporte - Managing Partner - lionel [a] bionest.com |
Before joining Bionest in June 2006, Lionel gained 10 years of managerial experience in strategic and organizational consultancy dedicated to the healthcare industry in consulting firms such as Monitor and ISO healthcare consulting. He managed over 150 assignments encompassing strategy, operations and organization for leading multinational pharmaceutical companies on local and international scales. Before entering consultancy, he held several operational positions at IMS health.
His main interest is strategy development. |
|
| |
 |
Alain J. Gilbert - Managing Partner - alain [a] bionest.com |
Before co-founding Bionest in 2003, Alain was European President of Biogen, where he founded its European operation for the launch of Avonex®. Prior to Biogen, he was European Founder of IDEXX Laboratories, a company involved in veterinary diagnostic. And prior to Iddexx, he served as President of Medtronic Europe, a world leader in cardiovascular devices.
He started his career in sales and marketing at Abbott's Diagnostic Division and remained there for 17 years, holding a number of key executive positions in the USA and Europe.
Today, he specialises in operational issues. |
|
| |
 |
Sean X. Hu - Managing Partner, North America -
shu [a] bionest.com |
| Sean brings more than 17 years of broad experience in life science consulting, industries and academia, including over six years in strategy consulting at IMS Management Consulting and AT Kearney where he advised a variety of life science companies on broad strategic issues. Sean is a published thought leader and experienced consulting advisor in the field of personalized medicine strategy, and has served as a representative on the FDA personalized medicine initiative consortium. Sean holds a PhD from NYU, and an MBA from the Wharton School of Business. His main interest is strategy development. |
|
|
|
